ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
PARALLEL-VT: A pilot study of simultaneous multi-wavefront left ventricular mapping for identification of critical ablation sites.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFunctional substrate mapping can identify ventricular tachycardia (VT) ablation targets. Multi-wavefront functional mapping can be laborious. In this study, we explored the feasibility, safety and utility of the new "parallel mapping" algorithm designed to streamline multi-wavefront activation mapping for VT.
methodsThis is a single center, prospective pilot study of adults undergoing scar-related VT ablation. Patients underwent endocardial and/or epicardial substrate parallel mapping using 2 distinct activation wavefronts (e.g. right ventricular [RV] and left ventricular [LV] pacing, 8 beats each). Slow-conducting regions were targeted for radiofrequency ablation. Short- and long-term outcomes were analyzed.
resultsOf the 41 ablation subjects, 19 (46.3%) underwent per-protocol parallel mapping. Protocol deviations mostly stemmed from incessant VT necessitating early ablation (n = 9, 40.9%). Most per-protocol treated subjects were male (n = 18, 94.7%) with a mean age of 66 ± 10 years and had a higher prevalence of ischemic heart disease compared to protocol deviations (94.7% vs. 54.6%, respectively, p = 0.005). Primary wavefront mapping was done during RV apical pacing. Secondary wavefront mapping chiefly relied on LV pacing (52.6%). The median procedure duration was 252 min (IQR 190-289). Adverse events occurred in 4 patients (21.1%; at most 1 event directly related to study protocol). In the first year of follow-up, seven (36.8%) individuals received appropriate ICD shocks and three (15.8%) patients died. In exploratory analyses, parallel mapping data appeared most informative in subjects with lateral wall scar.
conclusionParallel substrate mapping using multiple activation wavefronts is a novel, feasible and safe algorithm designed to identify ablation targets in patients with scar-related VT.
Indexed as
Identifiers
42089937What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.